SEGMENTS (Details)	3 Months Ended
	Mar. 31, 2023 USD ($) Facility	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($)
Segment Reporting Information [Abstract]
Number of FDA-licensed plasma collection facilities | Facility	8
Number of remaining plasma collection facilities under construction | Facility	10
Revenues	$ 56,913,534	$ 29,103,093
Cost of product revenue	40,400,544	25,441,046
Income (loss) from operations	(813,318)	(14,815,066)
Interest and other expense, net	(5,975,497)	(3,522,850)
Loss on extinguishment of debt	0	(6,669,941)
Net income (loss)	(6,788,815)	(25,007,857)
Capital expenditures	1,944,596	2,842,085
Depreciation and amortization expense	2,032,965	1,590,217
Total assets	340,787,542	308,032,492	$ 348,461,881
United States [Member]
Segment Reporting Information [Abstract]
Revenues	52,694,723	27,316,151
International [Member]
Segment Reporting Information [Abstract]
Revenues	4,218,811	1,786,942
Corporate [Member]
Segment Reporting Information [Abstract]
Revenues	35,708	35,708
Cost of product revenue	0	0
Income (loss) from operations	(5,343,425)	(6,509,288)
Interest and other expense, net	(5,951,491)	(3,472,854)
Loss on extinguishment of debt		(6,669,941)
Net income (loss)	(11,294,916)	(16,652,083)
Capital expenditures	0	0
Depreciation and amortization expense	0	763
Total assets	67,038,989	61,313,259
Operating Segments [Member] | ADMA BioManufacturing [Member]
Segment Reporting Information [Abstract]
Revenues	49,576,935	25,728,625
Cost of product revenue	33,933,782	22,213,781
Income (loss) from operations	5,476,441	(4,442,684)
Interest and other expense, net	(23,779)	(49,267)
Loss on extinguishment of debt		0
Net income (loss)	5,452,662	(4,491,951)
Capital expenditures	452,032	1,310,379
Depreciation and amortization expense	1,292,608	1,111,951
Total assets	234,894,891	214,150,322
Operating Segments [Member] | Plasma Collection Centers [Member]
Segment Reporting Information [Abstract]
Revenues	7,300,891	3,338,760
Cost of product revenue	6,466,762	3,227,265
Income (loss) from operations	(946,334)	(3,863,094)
Interest and other expense, net	(227)	(729)
Loss on extinguishment of debt		0
Net income (loss)	(946,561)	(3,863,823)
Capital expenditures	1,492,564	1,531,706
Depreciation and amortization expense	740,357	477,503
Total assets	$ 38,853,662	$ 32,568,911